Epidemiology of EML4–ALK translocations in a small, German non-small-cell lung cancer patient cohort

The emerging role of ALK inhibitors in the treatment of advanced non-small cell lung cancer

(2012) Domenico Galetta et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only

(2012) Yuki Togashi et al.   PLoS One

Targeting Anaplastic Lymphoma Kinase in Lung Cancer

(2011) A. T. Shaw et al.   CLINICAL CANCER RESEARCH

Histologic subtypes, immunohistochemistry, FISH or molecular screening for the accurate diagnosis of ALK-rearrangement in lung cancer: A comprehensive study of Caucasian non-smokers

(2011) Pierre-Alexandre Just et al.   LUNG CANCER

Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor

(2010) James E. Butrynski et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

(2010) Eunice L. Kwak et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

(2009) Alice T. Shaw et al.   JOURNAL OF CLINICAL ONCOLOGY

EML4-ALK: Honing In on a New Target in Non–Small-Cell Lung Cancer

(2009) Leora Horn et al.   JOURNAL OF CLINICAL ONCOLOGY